The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.
The surgical removal of one or both ovaries.
The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
Therapeutic use of hormones to alleviate the effects of hormone deficiency.
A coronary vasodilator agent.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
PLANT EXTRACTS and compounds, primarily ISOFLAVONES, that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.
Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.
One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.
Excision of the uterus.
Therapeutic replacement or supplementation of defective or missing enzymes to alleviate the effects of enzyme deficiency (e.g., GLUCOSYLCERAMIDASE replacement for GAUCHER DISEASE).
The giving of drugs, chemicals, or other substances by mouth.
One of the ESTROGEN RECEPTORS that has greater affinity for ISOFLAVONES than ESTROGEN RECEPTOR ALPHA does. There is great sequence homology with ER alpha in the DNA-binding domain but not in the ligand binding and hinge domains.
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
Tumors or cancer of the human BREAST.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares.
Elements of limited time intervals, contributing to particular results or situations.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Preoccupations with appearance or self-image causing significant distress or impairment in important areas of functioning.
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.
Material prepared from plants.
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.
An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Estrogen replacement therapy and breast cancer survival in a large screening study. (1/1512)

BACKGROUND: Hormone replacement therapy has been associated in some studies with reductions in breast cancer mortality among women who develop this disease. It is unclear whether this association reflects the biologic activity of the hormones or the earlier detection of tumors among hormone users. We examined breast cancer mortality among women who were diagnosed with axillary lymph node-negative and node-positive breast cancer according to the currency of estrogen use at diagnosis. METHODS: Vital status through June 1995 was determined for 2614 patients with postmenopausal breast cancer diagnosed during the period from 1973 to January 1981. We estimated adjusted hazard-rate ratios (adjusting for tumor size, age, race, Quetelet [body mass] index, and number of positive lymph nodes in women with node-positive disease) and unadjusted cumulative probabilities of breast cancer death over time since diagnosis. RESULTS: Among patients with node-negative disease, rate ratios for breast cancer mortality associated with current use compared with nonuse at diagnosis were 0.5 (95% confidence interval [CI] = 0.3-0.8) until 144 months after diagnosis and 2.2 (95% CI = 0.9-5.2) thereafter. Mortality was not statistically significantly lower in past users. The cumulative probabilities of breast cancer mortality at the end of follow-up were 0.14, 0.14, and 0.09 in nonusers, past users, and current users, respectively. Among women with node-positive disease, the rate ratios associated with current and past use were both 0.5 until 48 months after diagnosis (95% CI = 0.3-0.8 for current users; 95% CI = 0.3-0.9 for past users) and were 1.1 (95% CI = 0.7-1.7) and 1.8 (95% CI = 1.2-2.7), respectively, thereafter. The cumulative probabilities of breast cancer mortality were 0.32, 0.39, and 0.27 in nonusers, past users, and current users, respectively. CONCLUSIONS: Patients with breast cancer who were using replacement estrogens at the time of diagnosis experienced reductions in breast cancer mortality, which waned with the time since diagnosis.  (+info)

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study. (2/1512)

AIM: To study the histopathological features of breast carcinoma developing in postmenopausal patients on hormone replacement therapy (HRT). METHODS: The sample comprised 60 patients with invasive breast carcinoma including 31 who had received HRT at or shortly before presentation, and 29 who had not. Details concerning their tumour size, histological type and grade, lymph node status, and oestrogen and progesterone receptor status were compared. Immunoperoxidase staining for Bcl-2, p53, and E-cadherin was carried out on paraffin sections of all 60 patients. The results were then statistically analysed. RESULTS: Tumours detected in HRT patients were significantly smaller (mean 17 mm v 25 mm; p = 0.0156) and of a lower histological grade (p = 0.0414) than those detected in non-HRT patients. The incidence of invasive lobular carcinoma was slightly higher in HRT patients (19% v 14%). Immunohistologically, 87% of HRT tumours were Bcl-2 positive (compared with 79% in the control group), 29% were p53 positive (45% in the control), and 48% were E-cadherin positive (72% in the control group). Although the differences were not statistically significant there was a trend towards higher incidence of p53 negative and E-cadherin negative tumours in HRT patients. CONCLUSIONS: Breast carcinomas detected in patients on HRT have a significantly higher incidence of two favourable prognostic features (small size and a low histological grade). They also show a trend, statistically not significant, of being p53 negative and E-cadherin negative; this may be related to the slightly higher incidence of invasive lobular tumours in these patients.  (+info)

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. (3/1512)

The A2 allele of CYP17 has been associated with polycystic ovarian syndrome, elevated levels of certain steroid hormones in premenopausal women, and increased breast cancer risk. We prospectively assessed the association between the A2 allele of CYP17 and breast cancer risk in a case-control study nested within the Nurses' Health Study cohort. We also evaluated associations between this CYP17 genotype and plasma steroid hormone levels among postmenopausal controls not using hormone replacement to assess the biological significance of this genetic variant. Women with the A2 allele were not at an increased risk of incident breast cancer [OR (odds ratio), 0.85; 95% CI (confidence interval), 0.65-1.12] or advanced breast cancer (OR, 0.84; 95% CI, 0.54-1.32). We did observe evidence that the inverse association of late age at menarche with breast cancer may be modified by the CYP17 A2 allele. The protective effect of later age at menarche was only observed among women without the A2 allele (A1/A1 genotype: for age at menarche > or =13 versus <13; OR, 0.57; 95% CI, 0.36-0.90; A1/A2 and A2/A2 genotypes: OR, 1.05; 95% CI, 0.76-1.45; P for interaction = 0.07). Among controls, we found women with the A2/A2 genotype to have elevated levels of estrone (+14.3%, P = 0.01), estradiol (+13.8%, P = 0.08), testosterone (+8.6%, P = 0.34), androstenedione (+17.1%, P = 0.06), dehydroepiandrosterone (+14.4%, P = 0.02), and dehydroepiandrosterone sulfate (+7.2%, P = 0.26) compared with women with the A1/A1 genotype. These data suggest that the A2 allele of CYP17 modifies endogenous hormone levels, but is not a strong independent risk factor for breast cancer.  (+info)

Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. (4/1512)

A randomized open trial of hormone replacement therapy was used to assess changes in adductor pollicis muscle strength during 6-12 months of treatment with Prempak C 0.625(R) in comparison with an untreated control group. Muscle strength (maximal voluntary force; MVF), muscle cross-sectional area and bone mineral density were measured. Women entering the trial had oestrogen levels below 150 pmol.l-1, confirming their post-menopausal hormonal status. In the treated group, MVF increased by 12.4+/-1.0% (mean+/-S.E.M.) of initial MVF over the duration of treatment, while it declined slightly (2.9+/-0.9%) in the control group. This increase in strength could not be explained by an increase in muscle bulk, there being no significant increase in cross-sectional area during the study. Those subjects who were weakest at enrolment showed the greatest increases in muscle strength after treatment. Bone mineral density in total hip, Ward's triangle and total spine increased in the treated group, in agreement with previous studies. There was no correlation between the individual increases in bone mineral density and those in MVF.  (+info)

Osteoporosis: review of guidelines and consensus statements. (5/1512)

This activity is designed for physicians, pharmacists, nurses, health planners, directors of managed care organizations, and payers of health services. GOAL: To understand current guidelines and consensus statements regarding the prevention, diagnosis, and treatment of osteoporosis. OBJECTIVE: List four national or international organizations involved in the development of consensus statements regarding the prevention, diagnosis, and treatment of osteoporosis. 2. Discuss the significant differences among different countries regarding the prevention and treatment of osteoporosis. 3. List the major risk factors for osteoporosis. 4. Describe the differences in the application of bone mineral density scans, biochemical markers, and ultrasound in evaluating patients with suspected osteopenia and osteoporosis. 5. Distinguish between and briefly discuss therapeutic modalities used in primary prevention, secondary prevention, and treatment of osteoporosis. 6. Discuss the advantages and disadvantages of estrogen/hormone replacement therapy. 7. Describe alternatives to estrogen/hormone replacement therapy.  (+info)

Low use of long-term hormone replacement therapy in Denmark. (6/1512)

AIMS: To examine individual use of hormone replacement therapy (HRT) in a defined population of Danish women during a 5-year period. HRT may reduce osteoporosis and cardiovascular disease in postmenopausal women, but may also have side-effects. Little is known about the use of HRT in most populations. METHODS: A Pharmacoepidemiological Prescription Database was used to identify all reimbursed prescriptions for HRT in the county during the period 1991 to 1995. The Danish retail pharmacies' drug subsidy system made it possible to identify prescriptions by individual use. RESULTS: We examined 255797 HRT prescriptions issued during the period in the County of North Jutland. Total sales reached 16.5 million defined daily doses (DDDs), purchased by 31653 women, which corresponds to 26.9% of the female population above the age of 39 years. The annual prevalence proportion of current users rose from 10.4% to 14.8% during the study period, and the therapeutic intensity (DDD/1000 women/day) increased from 20.6 to 32.0. The mean DDD sum of systemic HRT per user was 73.4 in 1991; it and the proportion of users who received less than 90 DDD per year (83.4% in 1991) remained almost constant during the study period. The amount of oestrogen unopposed by progestin was high, 28.1% of all prescriptions. CONCLUSIONS: Less than one-fifth of the study population used HRT for more than 3 months per year, and only 32.8% of the women who were new users of HRT in 1992 continued this therapy throughout the study period.  (+info)

Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. (7/1512)

OBJECTIVE: To evaluate the impact on glucose and insulin metabolism of transdermal estrogen patches before and after the addition of cyclic dydrogesterone in postmenopausal women. DESIGN: We studied 21 postmenopausal women seeking treatment for symptomatic menopause. All patients received transdermal 50 micrograms/day estradiol for 24 weeks. After 12 weeks of treatment, 10 mg/day dydrogesterone were added. METHODS: During both regimens, insulin and C-peptide plasma concentrations were evaluated after an oral glucose tolerance test (OGTT); insulin sensitivity was evaluated by a hyperinsulinemic euglycemic clamp technique. Insulin and C-peptide response to OGTT were expressed as area under the curve (AUC) and as incremental AUC; insulin sensitivity was expressed as mg/kg body weight. Fractional hepatic insulin extraction (FHIE) was estimated by the difference between the incremental AUC of the C-peptide and insulin divided by the incremental AUC of the C-peptide. Plasma hormone and lipid concentrations were assessed at baseline and at 12 and 24 weeks of treatment. RESULTS: Nine patients proved to be hyperinsulinemic and 12 were normoinsulinemic. Transdermal estrogen treatment significantly decreased the insulin AUC (P < 0.05) and the insulin incremental AUC in hyperinsulinemic patients; addition of dydrogesterone further decreased both the AUC and incremental AUC of insulin. Estrogen alone and combined with dydrogesterone evoked a significant increase in C-peptide AUC in hyperinsulinemic (79.2%) and normoinsulinemic (113%) patients. The treatment increased the values for FHIE and insulin sensitivity in all patients (P < 0.04) and in the hyperinsulinemic group (P < 0.01), whereas it did not affect such parameters in normoinsulinemic patients. CONCLUSIONS: Transdermal estrogen substitution alone and combined with cyclical dydrogesterone may ameliorate hyperinsulinemia in a selected population of postmenopausal women.  (+info)

Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. (8/1512)

AIMS: The use of oestrogen containing hormone replacement therapy (HRT) is related to a significantly reduced atherosclerotic cardiovascular risk in postmenopausal women. Oestrogen is thought to be antioxidant and may inhibit low-density lipoprotein (LDL) oxidation in vitro. We investigated the effect of combined oestrogen and progestogen HRT on LDL oxidation in postmenopausal women. METHODS: Eighteen healthy women were given oestrogen/progestogen, and the susceptibility of LDL to oxidation was measured as the level of autoantibody to oxidative modified LDL and the production of conjugated dienes during copper-dependent oxidation after 3 and 6 months HRT. The levels of vitamin E, the major antioxidant in LDL, were also measured. RESULTS: After HRT, the anti-oxidatively modified LDL antibody level remained unchanged [1.58+/-0.16, 0.10 (-0.10, 0.26), and 0.08 (-0.09, 0.19), mean+/-s.d. at baseline, and mean change with 95% confidence intervals for differences at 3 and 6 months, respectively, P>0.05] as did the production of conjugated dienes when determined as lag phase [51.2+/-7.5, -0.3 (-3.9, 3.3), and 1.5 (-3.4, 6.4) min, P>0.05]. The LDL vitamin E content, measured as alpha-tocopherol, was also not altered [2.34+/-0.54, -0.07 (-0.27, 0.13), and -0.07 (-0.33, 0.16) nmol mg(-1) LDL, P>0.05] by treatment. CONCLUSIONS: Combined oestrogen and progestogen therapy for 6 months in postmenopausal women does not protect LDL against oxidation.  (+info)

Estrogen Replacement Therapy (ERT) is a medical treatment in which estrogen hormones are administered to replace the estrogen that is naturally produced by the ovaries but declines, especially during menopause. This therapy is often used to help manage symptoms of menopause such as hot flashes, night sweats, and vaginal dryness. It can also help prevent bone loss in postmenopausal women. ERT typically involves the use of estrogen alone, but in some cases, a combination of estrogen and progestin may be prescribed for women with a uterus to reduce the risk of endometrial cancer. However, ERT is associated with certain risks, including an increased risk of breast cancer, blood clots, and stroke, so it's important for women to discuss the potential benefits and risks with their healthcare provider before starting this therapy.

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

Ovariectomy is a surgical procedure in which one or both ovaries are removed. It is also known as "ovary removal" or "oophorectomy." This procedure is often performed as a treatment for various medical conditions, including ovarian cancer, endometriosis, uterine fibroids, and pelvic pain. Ovariectomy can also be part of a larger surgical procedure called an hysterectomy, in which the uterus is also removed.

In some cases, an ovariectomy may be performed as a preventative measure for individuals at high risk of developing ovarian cancer. This is known as a prophylactic ovariectomy. After an ovariectomy, a person will no longer have menstrual periods and will be unable to become pregnant naturally. Hormone replacement therapy may be recommended in some cases to help manage symptoms associated with the loss of hormones produced by the ovaries.

Postmenopause is a stage in a woman's life that follows 12 months after her last menstrual period (menopause) has occurred. During this stage, the ovaries no longer release eggs and produce lower levels of estrogen and progesterone hormones. The reduced levels of these hormones can lead to various physical changes and symptoms, such as hot flashes, vaginal dryness, and mood changes. Postmenopause is also associated with an increased risk of certain health conditions, including osteoporosis and heart disease. It's important for women in postmenopause to maintain a healthy lifestyle, including regular exercise, a balanced diet, and routine medical check-ups to monitor their overall health and manage any potential risks.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

Hormone Replacement Therapy (HRT) is a medical treatment that involves the use of hormones to replace or supplement those that the body is no longer producing or no longer producing in sufficient quantities. It is most commonly used to help manage symptoms associated with menopause and conditions related to hormonal imbalances.

In women, HRT typically involves the use of estrogen and/or progesterone to alleviate hot flashes, night sweats, vaginal dryness, and mood changes that can occur during menopause. In some cases, testosterone may also be prescribed to help improve energy levels, sex drive, and overall sense of well-being.

In men, HRT is often used to treat low testosterone levels (hypogonadism) and related symptoms such as fatigue, decreased muscle mass, and reduced sex drive.

It's important to note that while HRT can be effective in managing certain symptoms, it also carries potential risks, including an increased risk of blood clots, stroke, breast cancer (in women), and cardiovascular disease. Therefore, the decision to undergo HRT should be made carefully and discussed thoroughly with a healthcare provider.

I'm sorry for any confusion, but "Chromonar" does not appear to be a recognized medical term or substance. It is possible that you may have misspelled the word or it could be a term specific to a particular context within the medical field. If you have more information about where this term came from or its intended meaning, I'd be happy to help you try and clarify it further. However, without additional context, it is difficult for me to provide an accurate definition or explanation related to "Chromonar."

"Cutaneous administration" is a route of administering medication or treatment through the skin. This can be done through various methods such as:

1. Topical application: This involves applying the medication directly to the skin in the form of creams, ointments, gels, lotions, patches, or solutions. The medication is absorbed into the skin and enters the systemic circulation slowly over a period of time. Topical medications are often used for local effects, such as treating eczema, psoriasis, or fungal infections.

2. Iontophoresis: This method uses a mild electrical current to help a medication penetrate deeper into the skin. A positive charge is applied to a medication with a negative charge, or vice versa, causing it to be attracted through the skin. Iontophoresis is often used for local pain management and treating conditions like hyperhidrosis (excessive sweating).

3. Transdermal delivery systems: These are specialized patches that contain medication within them. The patch is applied to the skin, and as time passes, the medication is released through the skin and into the systemic circulation. This method allows for a steady, controlled release of medication over an extended period. Common examples include nicotine patches for smoking cessation and hormone replacement therapy patches.

Cutaneous administration offers several advantages, such as avoiding first-pass metabolism (which can reduce the effectiveness of oral medications), providing localized treatment, and allowing for self-administration in some cases. However, it may not be suitable for all types of medications or conditions, and potential side effects include skin irritation, allergic reactions, and systemic absorption leading to unwanted systemic effects.

Menopause is a natural biological process that typically occurs in women in their mid-40s to mid-50s. It marks the end of menstrual cycles and fertility, defined as the absence of menstruation for 12 consecutive months. This transition period can last several years and is often accompanied by various physical and emotional symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. The hormonal fluctuations during this time, particularly the decrease in estrogen levels, contribute to these symptoms. It's essential to monitor and manage these symptoms to maintain overall health and well-being during this phase of life.

Estrogen receptors (ERs) are a type of nuclear receptor protein that are expressed in various tissues and cells throughout the body. They play a critical role in the regulation of gene expression and cellular responses to the hormone estrogen. There are two main subtypes of ERs, ERα and ERβ, which have distinct molecular structures, expression patterns, and functions.

ERs function as transcription factors that bind to specific DNA sequences called estrogen response elements (EREs) in the promoter regions of target genes. When estrogen binds to the ER, it causes a conformational change in the receptor that allows it to recruit co-activator proteins and initiate transcription of the target gene. This process can lead to a variety of cellular responses, including changes in cell growth, differentiation, and metabolism.

Estrogen receptors are involved in a wide range of physiological processes, including the development and maintenance of female reproductive tissues, bone homeostasis, cardiovascular function, and cognitive function. They have also been implicated in various pathological conditions, such as breast cancer, endometrial cancer, and osteoporosis. As a result, ERs are an important target for therapeutic interventions in these diseases.

Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.

Phytoestrogens are compounds found in plants that have estrogen-like properties. They can bind to and activate or inhibit the action of estrogen receptors in the body, depending on their structure and concentration. Phytoestrogens are present in a variety of foods, including soy products, nuts, seeds, fruits, and vegetables.

Phytoestrogens have been studied for their potential health benefits, such as reducing the risk of hormone-dependent cancers (e.g., breast cancer), improving menopausal symptoms, and promoting bone health. However, their effects on human health are complex and not fully understood, and some studies suggest that high intake of phytoestrogens may have adverse effects in certain populations or under specific conditions.

It is important to note that while phytoestrogens can mimic the effects of estrogen in the body, they are generally weaker than endogenous estrogens produced by the human body. Therefore, their impact on hormonal balance and health outcomes may vary depending on individual factors such as age, sex, hormonal status, and overall diet.

Renal replacement therapy (RRT) is a medical treatment that takes over the normal function of the kidneys when they fail. The main objectives of RRT are to remove waste products and excess fluid, correct electrolyte imbalances, and maintain acid-base balance in the body. There are several types of RRT, including hemodialysis, peritoneal dialysis, and kidney transplantation.

Hemodialysis involves circulating the patient's blood through an external filter called a dialyzer, which removes waste products and excess fluid. The cleaned blood is then returned to the patient's body. Hemodialysis can be performed in a hospital or dialysis center, or at home with appropriate training.

Peritoneal dialysis involves instilling a special solution called dialysate into the patient's abdominal cavity, where it remains for a period of time to allow waste products and excess fluid to move from the bloodstream into the dialysate through a membrane in the peritoneum. The used dialysate is then drained out of the body and replaced with fresh dialysate. Peritoneal dialysis can be performed continuously or intermittently, and it can also be done at home.

Kidney transplantation involves surgically implanting a healthy kidney from a donor into the patient's body to replace the failed kidneys. This is usually the most effective form of RRT, but it requires major surgery and long-term immunosuppressive therapy to prevent rejection of the transplanted organ.

Overall, RRT is a life-sustaining treatment for patients with end-stage kidney disease, and it can significantly improve their quality of life and longevity.

Estrogen Receptor alpha (ERα) is a type of nuclear receptor protein that is activated by the hormone estrogen. It is encoded by the gene ESR1 and is primarily expressed in the cells of the reproductive system, breast, bone, liver, heart, and brain tissue.

When estrogen binds to ERα, it causes a conformational change in the receptor, which allows it to dimerize and translocate to the nucleus. Once in the nucleus, ERα functions as a transcription factor, binding to specific DNA sequences called estrogen response elements (EREs) and regulating the expression of target genes.

ERα plays important roles in various physiological processes, including the development and maintenance of female reproductive organs, bone homeostasis, and lipid metabolism. It is also a critical factor in the growth and progression of certain types of breast cancer, making ERα status an important consideration in the diagnosis and treatment of this disease.

A hysterectomy is a surgical procedure that involves the removal of the uterus (womb). Depending on the specific medical condition and necessity, a hysterectomy may also include the removal of the ovaries, fallopian tubes, and surrounding tissues. There are different types of hysterectomies, including:

1. Total hysterectomy: The uterus and cervix are removed.
2. Supracervical (or subtotal) hysterectomy: Only the upper part of the uterus is removed, leaving the cervix intact.
3. Radical hysterectomy: This procedure involves removing the uterus, cervix, surrounding tissues, and the upper part of the vagina. It is typically performed in cases of cervical cancer.
4. Oophorectomy: The removal of one or both ovaries can be performed along with a hysterectomy depending on the patient's medical condition and age.
5. Salpingectomy: The removal of one or both fallopian tubes can also be performed along with a hysterectomy if needed.

The reasons for performing a hysterectomy may include but are not limited to: uterine fibroids, heavy menstrual bleeding, endometriosis, adenomyosis, pelvic prolapse, cervical or uterine cancer, and chronic pelvic pain. The choice of the type of hysterectomy depends on the patient's medical condition, age, and personal preferences.

Enzyme Replacement Therapy (ERT) is a medical treatment approach in which functional copies of a missing or deficient enzyme are introduced into the body to compensate for the lack of enzymatic activity caused by a genetic disorder. This therapy is primarily used to manage lysosomal storage diseases, such as Gaucher disease, Fabry disease, Pompe disease, and Mucopolysaccharidoses (MPS), among others.

In ERT, the required enzyme is produced recombinantly in a laboratory using biotechnological methods. The purified enzyme is then administered to the patient intravenously at regular intervals. Once inside the body, the exogenous enzyme is taken up by cells, particularly those affected by the disorder, and helps restore normal cellular functions by participating in essential metabolic pathways.

ERT aims to alleviate disease symptoms, slow down disease progression, improve quality of life, and increase survival rates for patients with lysosomal storage disorders. However, it does not cure the underlying genetic defect responsible for the enzyme deficiency.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

Estrogen Receptor beta (ER-β) is a protein that is encoded by the gene ESR2 in humans. It belongs to the family of nuclear receptors, which are transcription factors that regulate gene expression in response to hormonal signals. ER-β is one of two main estrogen receptors, the other being Estrogen Receptor alpha (ER-α), and it plays an important role in mediating the effects of estrogens in various tissues, including the breast, uterus, bone, brain, and cardiovascular system.

Estrogens are steroid hormones that play a critical role in the development and maintenance of female reproductive and sexual function. They also have important functions in other tissues, such as maintaining bone density and promoting cognitive function. ER-β is widely expressed in many tissues, including those outside of the reproductive system, suggesting that it may have diverse physiological roles beyond estrogen-mediated reproduction.

ER-β has been shown to have both overlapping and distinct functions from ER-α, and its expression patterns differ between tissues. For example, in the breast, ER-β is expressed at higher levels in normal tissue compared to cancerous tissue, suggesting that it may play a protective role against breast cancer development. In contrast, in the uterus, ER-β has been shown to have anti-proliferative effects and may protect against endometrial cancer.

Overall, ER-β is an important mediator of estrogen signaling and has diverse physiological roles in various tissues. Understanding its functions and regulation may provide insights into the development of novel therapies for a range of diseases, including cancer, osteoporosis, and cardiovascular disease.

Endometrial neoplasms refer to abnormal growths or tumors in the endometrium, which is the innermost lining of the uterus. These neoplasms can be benign (non-cancerous) or malignant (cancerous). The two main types of endometrial cancer are type I, also known as endometrioid adenocarcinoma, and type II, which includes serous carcinoma, clear cell carcinoma, and carcinosarcoma.

Type I endometrial cancers are usually estrogen-dependent and associated with risk factors such as obesity, diabetes, and prolonged exposure to estrogen without progesterone. They tend to grow more slowly and have a better prognosis than type II cancers.

Type II endometrial cancers are less common but more aggressive, often presenting at an advanced stage and having a worse prognosis. They are not typically associated with hormonal factors and may occur in women who have gone through menopause.

Endometrial neoplasms can also include benign growths such as polyps, hyperplasia, and endometriosis. While these conditions are not cancerous, they can increase the risk of developing endometrial cancer and should be monitored closely by a healthcare provider.

"Macaca fascicularis" is the scientific name for the crab-eating macaque, also known as the long-tailed macaque. It's a species of monkey that is native to Southeast Asia. They are called "crab-eating" macaques because they are known to eat crabs and other crustaceans. These monkeys are omnivorous and their diet also includes fruits, seeds, insects, and occasionally smaller vertebrates.

Crab-eating macaques are highly adaptable and can be found in a wide range of habitats, including forests, grasslands, and wetlands. They are also known to live in close proximity to human settlements and are often considered pests due to their tendency to raid crops and steal food from humans.

These monkeys are social animals and live in large groups called troops. They have a complex social structure with a clear hierarchy and dominant males. Crab-eating macaques are also known for their intelligence and problem-solving abilities.

In medical research, crab-eating macaques are often used as animal models due to their close genetic relationship to humans. They are used in studies related to infectious diseases, neuroscience, and reproductive biology, among others.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.

Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.

Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

In the context of medicine, risk is the probability or likelihood of an adverse health effect or the occurrence of a negative event related to treatment or exposure to certain hazards. It is usually expressed as a ratio or percentage and can be influenced by various factors such as age, gender, lifestyle, genetics, and environmental conditions. Risk assessment involves identifying, quantifying, and prioritizing risks to make informed decisions about prevention, mitigation, or treatment strategies.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

A cross-over study is a type of experimental design in which participants receive two or more interventions in a specific order. After a washout period, each participant receives the opposite intervention(s). The primary advantage of this design is that it controls for individual variability by allowing each participant to act as their own control.

In medical research, cross-over studies are often used to compare the efficacy or safety of two treatments. For example, a researcher might conduct a cross-over study to compare the effectiveness of two different medications for treating high blood pressure. Half of the participants would be randomly assigned to receive one medication first and then switch to the other medication after a washout period. The other half of the participants would receive the opposite order of treatments.

Cross-over studies can provide valuable insights into the relative merits of different interventions, but they also have some limitations. For example, they may not be suitable for studying conditions that are chronic or irreversible, as it may not be possible to completely reverse the effects of the first intervention before administering the second one. Additionally, carryover effects from the first intervention can confound the results if they persist into the second treatment period.

Overall, cross-over studies are a useful tool in medical research when used appropriately and with careful consideration of their limitations.

Equilenin is an estrogen compound that is found in certain plants and is also produced synthetically. It is structurally similar to the natural estrogens produced by the human body, such as estradiol and estrone. Equilenin has been used in some forms of hormone replacement therapy and in the treatment of certain medical conditions, such as breast cancer and prostate cancer. However, its use is not as common as other synthetic estrogens due to its potential side effects and risks.

Like other estrogen compounds, equilenin works by binding to estrogen receptors in the body, which are found in various tissues including the breasts, uterus, bones, and brain. This binding action can stimulate cell growth and development, as well as regulate various physiological processes such as bone density, cholesterol levels, and mood.

It is important to note that the use of estrogen therapy, including equilenin, carries certain risks, particularly for postmenopausal women. Long-term use of estrogen therapy has been associated with an increased risk of breast cancer, endometrial cancer, stroke, and blood clots. Therefore, it should only be used under the close supervision of a healthcare provider and for the shortest duration necessary to treat the underlying medical condition.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Lipids are a broad group of organic compounds that are insoluble in water but soluble in nonpolar organic solvents. They include fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E, and K), monoglycerides, diglycerides, triglycerides, and phospholipids. Lipids serve many important functions in the body, including energy storage, acting as structural components of cell membranes, and serving as signaling molecules. High levels of certain lipids, particularly cholesterol and triglycerides, in the blood are associated with an increased risk of cardiovascular disease.

The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.

Selective estrogen receptor modulators (SERMs) are a class of medications that act as either agonists or antagonists on the estrogen receptors in different tissues of the body. They selectively bind to estrogen receptors and can have opposite effects depending on the target tissue. In some tissues, such as bone and liver, SERMs behave like estrogens and stimulate estrogen receptors, promoting bone formation and reducing cholesterol levels. In contrast, in other tissues, such as breast and uterus, SERMs block the effects of estrogen, acting as estrogen antagonists and preventing the growth of hormone-sensitive tumors.

Examples of SERMs include:

* Tamoxifen: used for the prevention and treatment of breast cancer in both pre- and postmenopausal women.
* Raloxifene: used for the prevention and treatment of osteoporosis in postmenopausal women, as well as for reducing the risk of invasive breast cancer in high-risk postmenopausal women.
* Toremifene: used for the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive tumors.
* Lasofoxifene: used for the prevention and treatment of osteoporosis in postmenopausal women, as well as reducing the risk of invasive breast cancer in high-risk postmenopausal women.

It is important to note that SERMs can have side effects, including hot flashes, vaginal dryness, and an increased risk of blood clots. The choice of a specific SERM depends on the individual patient's needs, medical history, and potential risks.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Coronary artery disease, often simply referred to as coronary disease, is a condition in which the blood vessels that supply oxygen-rich blood to the heart become narrowed or blocked due to the buildup of fatty deposits called plaques. This can lead to chest pain (angina), shortness of breath, or in severe cases, a heart attack.

The medical definition of coronary artery disease is:

A condition characterized by the accumulation of atheromatous plaques in the walls of the coronary arteries, leading to decreased blood flow and oxygen supply to the myocardium (heart muscle). This can result in symptoms such as angina pectoris, shortness of breath, or arrhythmias, and may ultimately lead to myocardial infarction (heart attack) or heart failure.

Risk factors for coronary artery disease include age, smoking, high blood pressure, high cholesterol, diabetes, obesity, physical inactivity, and a family history of the condition. Lifestyle changes such as quitting smoking, exercising regularly, eating a healthy diet, and managing stress can help reduce the risk of developing coronary artery disease. Medical treatments may include medications to control blood pressure, cholesterol levels, or irregular heart rhythms, as well as procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

Body Dysmorphic Disorder (BDD) is a mental health condition where an individual becomes obsessed with perceived flaws or defects in their appearance, which are often either minimal or not observable to others. The preoccupation with these real or imagined physical imperfections can cause significant distress and impairment in social, occupational, and other areas of functioning.

Individuals with BDD may spend excessive time examining themselves in the mirror, seeking reassurance from others, or trying to camouflage or cover up their perceived flaws. They may also engage in repetitive behaviors such as skin picking, hair pulling, or excessive grooming. The obsessions and compulsions related to BDD can lead to significant anxiety, depression, and social isolation.

BDD typically begins in adolescence and is more common in women than men. It is important to note that BDD is different from normal concerns about appearance, as the preoccupation with perceived flaws in BDD is excessive and causes significant distress or impairment. Treatment for BDD often involves a combination of medication and cognitive-behavioral therapy (CBT).

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Estrone is a type of estrogen, which is a female sex hormone. It's one of the three major naturally occurring estrogens in women, along with estradiol and estriol. Estrone is weaker than estradiol but has a longer half-life, meaning it remains active in the body for a longer period of time.

Estrone is produced primarily in the ovaries, adrenal glands, and fat tissue. In postmenopausal women, when the ovaries stop producing estradiol, estrone becomes the dominant form of estrogen. It plays a role in maintaining bone density, regulating the menstrual cycle, and supporting the development and maintenance of female sexual characteristics.

Like other forms of estrogen, estrone can also have effects on various tissues throughout the body, including the brain, heart, and breast tissue. Abnormal levels of estrone, either too high or too low, can contribute to a variety of health issues, such as osteoporosis, menstrual irregularities, and increased risk of certain types of cancer.

Estriol is a type of estrogen, which is a female sex hormone. It is produced in the placenta during pregnancy and is used as a marker for fetal growth and development. Estriol levels can be measured in the mother's urine or blood to assess fetal well-being during pregnancy. Additionally, synthetic forms of estriol are sometimes used in hormone replacement therapy to treat symptoms of menopause.

"Plant preparations" is not a term with a specific medical definition in the field of medicine or pharmacology. However, it is commonly used to refer to various forms of plant material that have been prepared for medicinal use. This can include dried and powdered plant parts, such as leaves, roots, or flowers, as well as extracts or concentrates made from plants. These preparations may be used in traditional medicine or as the basis for modern pharmaceuticals. It is important to note that the safety, effectiveness, and quality of plant preparations can vary widely, and they should only be used under the guidance of a qualified healthcare provider.

A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.

Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.

Some common examples of drug implants include:

1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.

Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.

Postmenopausal osteoporosis is a specific type of osteoporosis that occurs in women after they have gone through menopause. It is defined as a skeletal disorder characterized by compromised bone strength, leading to an increased risk of fractures. In this condition, the decline in estrogen levels that occurs during menopause accelerates bone loss, resulting in a decrease in bone density and quality, which can lead to fragility fractures, particularly in the hips, wrists, and spine.

It's important to note that while postmenopausal osteoporosis is more common in women, men can also develop osteoporosis due to other factors such as aging, lifestyle choices, and medical conditions.

Alpha-galactosidase is an enzyme that breaks down complex carbohydrates, specifically those containing alpha-galactose molecules. This enzyme is found in humans, animals, and microorganisms. In humans, a deficiency of this enzyme can lead to a genetic disorder known as Fabry disease, which is characterized by the accumulation of these complex carbohydrates in various tissues and organs, leading to progressive damage. Alpha-galactosidase is also used as a medication for the treatment of Fabry disease, where it is administered intravenously to help break down the accumulated carbohydrates and alleviate symptoms.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Testosterone is a steroid hormone that belongs to androsten class of hormones. It is primarily secreted by the Leydig cells in the testes of males and, to a lesser extent, by the ovaries and adrenal glands in females. Testosterone is the main male sex hormone and anabolic steroid. It plays a key role in the development of masculine characteristics, such as body hair and muscle mass, and contributes to bone density, fat distribution, red cell production, and sex drive. In females, testosterone contributes to sexual desire and bone health. Testosterone is synthesized from cholesterol and its production is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Isoflavones are a type of plant-derived compounds called phytoestrogens, which have a chemical structure similar to human estrogen. They are found in various plants, particularly in soybeans and soy products. Isoflavones can act as weak estrogens or anti-estrogens in the body, depending on the levels of natural hormones present. These compounds have been studied for their potential health benefits, including reducing menopausal symptoms, improving cardiovascular health, and preventing certain types of cancer. However, more research is needed to fully understand their effects and safety.

Fabry disease is a rare X-linked inherited lysosomal storage disorder caused by mutations in the GLA gene, which encodes the enzyme alpha-galactosidase A. This enzyme deficiency leads to the accumulation of glycosphingolipids, particularly globotriaosylceramide (Gb3 or GL-3), in various tissues and organs throughout the body. The accumulation of these lipids results in progressive damage to multiple organ systems, including the heart, kidneys, nerves, and skin.

The symptoms of Fabry disease can vary widely among affected individuals, but common manifestations include:

1. Pain: Acroparesthesias (burning or tingling sensations) in the hands and feet, episodic pain crises, chronic pain, and neuropathy.
2. Skin: Angiokeratomas (small, red, rough bumps on the skin), hypohidrosis (decreased sweating), and anhydrosis (absent sweating).
3. Gastrointestinal: Abdominal pain, diarrhea, constipation, nausea, and vomiting.
4. Cardiovascular: Left ventricular hypertrophy (enlargement of the heart muscle), cardiomyopathy, ischemic heart disease, arrhythmias, and valvular abnormalities.
5. Renal: Proteinuria (protein in the urine), hematuria (blood in the urine), chronic kidney disease, and end-stage renal disease.
6. Nervous system: Hearing loss, tinnitus, vertigo, stroke, and cognitive decline.
7. Ocular: Corneal opacities, cataracts, and retinal vessel abnormalities.
8. Pulmonary: Chronic cough, bronchial hyperresponsiveness, and restrictive lung disease.
9. Reproductive system: Erectile dysfunction in males and menstrual irregularities in females.

Fabry disease affects both males and females, but the severity of symptoms is generally more pronounced in males due to the X-linked inheritance pattern. Early diagnosis and treatment with enzyme replacement therapy (ERT) or chaperone therapy can help manage the progression of the disease and improve quality of life.

Acute kidney injury (AKI), also known as acute renal failure, is a rapid loss of kidney function that occurs over a few hours or days. It is defined as an increase in the serum creatinine level by 0.3 mg/dL within 48 hours or an increase in the creatinine level to more than 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days, or a urine volume of less than 0.5 mL/kg per hour for six hours.

AKI can be caused by a variety of conditions, including decreased blood flow to the kidneys, obstruction of the urinary tract, exposure to toxic substances, and certain medications. Symptoms of AKI may include decreased urine output, fluid retention, electrolyte imbalances, and metabolic acidosis. Treatment typically involves addressing the underlying cause of the injury and providing supportive care, such as dialysis, to help maintain kidney function until the injury resolves.

Ruggiero, Ronald J.; Likis, Frances E. (2002). "Estrogen: physiology, pharmacology, and formulations for replacement therapy". ... Estrogen is a critical sex hormone for women (in conjunction with progesterone). Estrogen is responsible for all different ... This termination of menses is associated with a dramatic drop in estrogen levels. The estrogen levels stated previously ... Androgen-dependent condition Estrogen insensitivity syndrome "Estrogen: Hormone, Function, Levels & Imbalances". Cleveland ...
Menopausal hormone therapy with replacement dosages of estrogens and progestogens has been associated with a significantly ... 3. Estrogen preparations and combination preparations]" [Estrogen therapy in practice. 3. Estrogen preparations and combination ... 0.3 with continuous estrogen-progestogen therapy). Continuous estrogen-progestogen therapy is more protective than sequential ... Estrogens appear to be useful in the treatment of schizophrenia in both women and men. Systemic estrogen therapy at adequate ...
Estrogen Replacement Therapy (HRT) is a kind of hormone replacement therapy. Its goal is to mitigate discomfort caused by ... Estrogen Replacement Therapy has shown some positive effects with postmenopausal women. Estrogen and estrogen-like molecules ... These unexpected diseases hindered estrogen to get involved in neurodegenerative disease therapy. So, when applying estrogen- ... Plant Estrogens (Phytoestrogens); 3) Fungi Estrogens (Mycoestrogens) and 4) Synthetic Estrogens (xenoestrogens). Xenoestrogens ...
Watkins, Elizabeth Siegel (2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. Baltimore: Johns ... Robinson, Roger W (1958). "Estrogen Replacement Therapy in women with coronary atherosclerosis". Annals of Internal Medicine. ... Robinson, Roger W (1956). "Effects of Estrogen Therapy on Hormonal Functions and Serum Lipids in Men with Coronary ... His research led to the identification of lipid-lowering effects of the female hormone estrogen and he performed the earliest ...
... , as part of hormone replacement therapy (HRT), is frequently used to treat symptoms caused by estrogen deficiency in ... Ruggiero RJ, Likis FE (2002). "Estrogen: physiology, pharmacology, and formulations for replacement therapy". Journal of ... Estrone is an estrogen, specifically an agonist of the estrogen receptors ERα and ERβ. It is a far less potent estrogen than is ... The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. pp. 21-. ISBN 978-0-8018-8602-7. Pincus G ...
Ruggiero RJ, Likis FE (2002). "Estrogen: physiology, pharmacology, and formulations for replacement therapy". J Midwifery ... Wolf AS, Schneider HP (1989). Östrogene in Diagnostik und Therapie [Estrogens in Diagnostics and Therapy]. Springer-Verlag. pp ... Estradiol is a naturally occurring and bioidentical estrogen, or an agonist of the estrogen receptor, the biological target of ... Oettel M, Schillinger E (1999). Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and ...
It is associated with hormone replacement therapy (estrogen). The risk is higher in white women than other ethnicities, ...
Ruggiero RJ, Likis FE (2002). "Estrogen: physiology, pharmacology, and formulations for replacement therapy". Journal of ... "Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression". FASEB ... In accordance, replacement of spironolactone with canrenone in male patients has been found to reverse spironolactone-induced ... The medication has also been found to interact very weakly with the estrogen and progesterone receptors, and to act as an ...
"17 beta-estradiol for postmenopausal estrogen replacement therapy". Obstetrical & Gynecological Survey. 39 (4): 230-245. doi: ... A contribution to therapy with depot estrogens]" [Estrogen excretion during the cycle and after injection of estradiol esters. ... Estradiol benzoate is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like ... is an estrogen medication which is used in hormone therapy for menopausal symptoms and low estrogen levels in women, in hormone ...
"Blood Is Less Sticky With Estrogen Replacement Therapy". ScienceDaily. Retrieved 2019-12-18. "Dr. Rosenson on Cholesterol". ... Robert Rosenson: Cholesterol therapy in high-risk CHD patients, retrieved 2019-12-18 "Robert S. Rosenson - Chief, Director, ... Robert S. Rosenson studies the effects of lipid-lowering therapy in different regions of the United States. He researches ... "Lipid-Lowering Therapy in Different Regions of the United States: Insights from Getting to an Improved Understanding of Low- ...
Premarin, a hormone replacement therapy, is a conjugated estrogen. It was first available in the form of a preparation ... Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. ... Replacement refers to the preferred use of non-animal methods over animal methods whenever it is possible to achieve the same ... PDQ® Integrative, Alternative, and Complementary Therapies Editorial Board (23 August 2018). "Cartilage (Bovine and Shark) (PDQ ...
Uhler, M. L.; Marks, J. W.; Judd, H. L. (May 2000). "Estrogen replacement therapy and gallbladder disease in postmenopausal ... conjugated equine estrogen; CEE) and estrogen-plus-progestin (conjugated equine estrogen with medroxyprogesterone; CEE+MPA ). ... The Heart and Estrogen/progestin Replacement Study". Annals of Internal Medicine. 135 (7): 493-501. doi:10.7326/0003-4819-135-7 ... "Effect of estrogen therapy on gallbladder disease" (PDF). JAMA. 293 (3): 330-339. doi:10.1001/jama.293.3.330. ISSN 1538-3598. ...
Hormone replacement therapy (HRT) includes both estrogen and progesterone. They are used for treating menopausal symptoms. A ... Gordhandas S, Norquist BM, Pennington KP, Yung RL, Laya MB, Swisher EM (April 2019). "Hormone replacement therapy after risk ... Colditz GA, Egan KM, Stampfer MJ (May 1993). "Hormone replacement therapy and risk of breast cancer: results from epidemiologic ... Collaborative Group on Hormonal Factors in Breast Cancer (1997). "Breast cancer and hormone replacement therapy: collaborative ...
... implicating high levels of estrogen and progesterone in this effect. Hormone replacement therapy Estrogen deprivation therapy ... High-dose estrogen therapy (HDE) is a type of hormone therapy in which high doses of estrogens are given. When given in ... The following steroidal estrogens have been used in HDE therapy: Conjugated estrogens (Premarin) Estradiol and estradiol esters ... Estrogens are agonists of the estrogen receptors (ERs), the biological target of endogenous estrogens such as estradiol. When ...
Elizabeth Siegel Watkins (16 April 2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. ... Danish endocrinologist Christian Hamburger publishes one of the earliest reports on hormone therapy in transgender women, ... and provides free hormone therapy; 1974 Chile allows a trans woman, Marcia Torres, to legally change her name and gender on the ...
Watkins ES (6 March 2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. pp. 21-. ISBN ... Estrone is an estrogen, specifically an agonist of the estrogen receptors (ERs) ERα and ERβ. It is a far less potent estrogen ... Krishna UR, Sheriar NK, Mandlekar A (1996). "Hormone Replacement Therapy". In Krishna UR, Sheriar NK (eds.). Menopause. Orient ... 1) (Butenandt 1931). Hammond CB, Maxson WS (January 1982). "Current status of estrogen therapy for the menopause". Fertility ...
If someone is under Estrogen Replacement Therapy for a long time. Smoking habits may also lead to the same. [1] Treatment:[ ... Radiation therapy to prevent the cancerous cells from developing. The tumor forms in the ovaries and gradually spreads to the ...
Testosterone replacement therapy also appears to be associated with lower Lp(a) levels. Estrogen replacement therapy in post- ... "The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic ... Niacin therapy may reduce Lp(a) levels by 20-30%. A meta-analysis suggested that atorvastatin may lower Lp(a) levels. In severe ... However, there have not been enough studies to determine which therapies might be beneficial. Lp(a) has been shown to interact ...
In addition, PEP is used in hormone replacement therapy for low estrogen levels due to hypogonadism or menopause in women. It ... Renaissance of estrogen therapy in advanced prostate carcinoma?]" [Renaissance of estrogen therapy in advanced prostate ... Mazer NA (2004). "Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women". Thyroid. 14 (Suppl ... PEP is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. It is ...
Watkins, Elizabeth Siegel (2007). The estrogen elixir : a history of hormone replacement therapy in America. Baltimore: Johns ...
From the 1940s until the late 1980s, DES was FDA-approved as estrogen replacement therapy for estrogen deficiency states such ... 3. Estrogen preparations and combination preparations]" [Estrogen therapy in practice. 3. Estrogen preparations and combination ... Watkins ES (16 April 2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. pp. 26-. ISBN ... DES is an estrogen, or an agonist of the estrogen receptors, the biological target of estrogens like estradiol. It is a ...
She began her estrogen hormone replacement therapy when she was 18. She had undergone silicone and electrolysis treatment. ...
Estrogen replacement may interfere with growth hormone therapy, due to the closing effects of estrogen on growth plates; ... Estrogen replacement therapy such as the birth control pill, has been used since the condition was described in 1938 to promote ... Estrogen replacement therapy can promote development of the breasts and hips. Medical care is often required to manage other ... Pregnancy in Turner syndrome is inherently high-risk; the maternal death rate is 2%. Usually, estrogen replacement therapy is ...
Speth RC, D'Ambra M, Ji H, Sandberg K (December 2018). "A heartfelt message, estrogen replacement therapy: use it or lose it". ... Hodis HN, Mack WJ (July 2014). "Hormone replacement therapy and the association with coronary heart disease and overall ... Gordon JL, Girdler SS (December 2014). "Hormone replacement therapy in the treatment of perimenopausal depression". Curr ... "Estrogen plus progestin therapy and breast cancer in recently postmenopausal women". Am J Epidemiol. 167 (10): 1207-16. doi: ...
Elizabeth Siegel Watkins (16 April 2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. ... Wilson promoted the use of estrogen therapy to avoid the menopause and associated symptoms. He characterized menopause as a ... "Hormone Replacement Study A Shock to the Medical System". The New York Times. 10 July 2002. Retrieved 4 April 2023. Daniel Lee ... Within 10 years of the publishing of his book, in which Wilson promoted the use of conjugated estrogens (Premarin) and of ...
Elizabeth Siegel Watkins (16 April 2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. JHU Press. ... and associated symptoms as a serious disease state and strongly advocated the use of estrogen-based menopausal hormone therapy ... with it having been implicated in causing a rapid and large rise in prescriptions of menopausal hormone therapy. Subsequently, ... trials such as the Women's Health Initiative (WHI) contradicted Wilson's claims and showed that menopausal hormone therapy ...
Sherwin BB (1988). "Affective changes with estrogen and androgen replacement therapy in surgically menopausal women". J Affect ... EDE is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. It is ... "Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women". ... Sherwin BB, Gelfand MM, Schucher R, Gabor J (February 1987). "Postmenopausal estrogen and androgen replacement and lipoprotein ...
Sherwin BB (1988). "Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women". ... Sherwin BB (1988). "Affective changes with estrogen and androgen replacement therapy in surgically menopausal women". J Affect ... Sherwin BB, Gelfand MM, Schucher R, Gabor J (February 1987). "Postmenopausal estrogen and androgen replacement and lipoprotein ... 641-. ISBN 978-1-4757-2085-3. Al-Imari L, Wolfman WL (September 2012). "The safety of testosterone therapy in women". J Obstet ...
Beck KL, Anderson MC, Kirk JK (August 2017). "Transdermal estrogens in the changing landscape of hormone replacement therapy". ... Estrogen therapies, including the use of an estrogen patch, can be used to alleviate these symptoms by increasing estrogen ... Premenopausal women may be recommended to take progestin with estrogen therapy. Estrogen patches may be effective in preventing ... An estrogen patch, or oestrogen patch, is a transdermal delivery system for estrogens such as estradiol and ethinylestradiol ...
Likewise, post-menopausal estrogen replacement is safe in patients with prolactinoma treated with medical therapy or surgery.[ ... They may also want to discuss testosterone/estrogen replacement therapy with their physician.[citation needed] If a woman has ... If medical therapy is only partially successful, this therapy should continue, possibly combined with surgery or radiation ... Hyperprolactinemia can cause reduced estrogen production in women and reduced testosterone production in men. Although estrogen ...
Hormone Replacement Therapy): learn about side effects, dosage, special precautions, and more on MedlinePlus ... Estrogen and progestin are two female sex hormones. Hormone replacement therapy works by replacing estrogen hormone that is no ... Before taking hormone replacement therapy,. *tell your doctor and pharmacist if you are allergic to estrogen, progestin, or any ... Estrogen and Progestin (Hormone Replacement Therapy). pronounced as (ess troe jen) (pro jes tin) ...
Both the surrogate mother and egg donor must undergo estrogen replacement therapy. This is how it works. ... Estrogen Replacement Therapy. Both the egg donor and the surrogate mother will undergo estrogen replacement therapy once ...
Estrogen Replacement Therapy May Increase Risk of Dementia ... 11: Estrogen Replacement Therapy May Increase Risk of Dementia ... estrogen-only replacement therapy in postmenopausal women whove had a hysterectomy not only fails to prevent memory loss but ... For years hormone replacement therapy was promoted as a defense against a host of age-related ailments. Over the last two years ... And the study did not address whether hormone replacement therapy given during early menopause might offer cognitive protection ...
Instructions for estrogen and hormone replacement therapy including taking the medications, side effects and adverse reactions ... How to Take Estrogen and Hormone Replacement Therapy. Background. Estrogens are the class of hormones responsible for many ... Hormone replacement therapy with estrogen and progesterone (HRT) is given if a woman has not had a hysterectomy (to avoid ... Any one or combination of the natural estrogens can be used as replacement therapy as well as synthetic, manufactured and even ...
Fluctuating estrogen levels accompany the perimenopausal transition. Thus, estrogen replacement therapy (ERT) has been proposed ... Estrogen Replacement Therapy in the Treatment of Major Depressive Disorder in Perimenopausal Women. Natalie L. Rasgon, MD, PhD ... Eighty percent of patients had significant response to therapy, with 70% showing diagnosti.... J Clin Psychiatry 2024;85(1): ... Acceptance and Mindfulness-Based Exposure Therapy for PTSD After Cardiac Arrest. ...
Research, Technology, Methods , therapeutics , drug therapy , hormone replacement therapy , estrogen replacement therapy ... The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects ... This may also include the use of progestational agents in combination therapy. ...
Here, learn how having low estrogen, possibly due to menopause, can lead to osteoporosis. ... Estrogen plays an important role in maintaining bone structure. ... estrogen replacement therapy (ERT). to prevent or reverse ... www.endocrineweb.com/conditions/osteoporosis/estrogen-replacement-therapy-osteoporosis. *. Cauley, J. A. (2015). Estrogen and ... What happens when estrogen levels are low?. Low estrogen levels can cause a range of symptoms. This article includes details on ...
An estrogen imbalance may cause hot flashes, vaginal dryness, and low libido. Estrogen replacement therapy is available in ... that may be able to replace estrogen that has been naturally lost due to aging. ... Bioidentical estrogen is a bioidentical hormone replacement therapy (BHRT) ... Bioidentical Estrogen Replacement Therapy. Bioidentical estrogen is a form of bioidentical hormone replacement therapy (BHRT). ...
Browse Estrogen news, research and analysis from The Conversation ... Menopause? Start estrogen replacement therapy sooner, to reduce ... Research in mice shows that estrogen replacement therapy has the greatest chance of reducing cardiovascular disease risk if it ... Hormone replacement therapy and cancer? Lets get the facts straight. Henry Burger, Hudson Institute ... The authors of the 2003 Million Women Study were wrong to conclude their investigation proved that hormone replacement therapy ...
Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. ... Data regarding use of estrogen plus progestogen or estrogen alone were obtained in interviews. RESULTS: The analysis was based ...
Estrogen Replacement Therapy* / adverse effects * Female * Humans * Postmenopause* Grants and funding * Z01 MH002537-18/ImNIH/ ... Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society ... in March 2007 regarding its recommendations for menopausal hormone therapy (HT) for postmenopausal women, with consideration ...
NHS medicines information on vaginal oestrogen - what its used for, side effects, dosage and who can use it. ... Back to Hormone replacement therapy (HRT) Vaginal oestrogen - Brand names: Vagifem, Gina, Ovestin, Vagirux Find out how vaginal ... oestrogen treats vaginal dryness caused by menopause, and how to take it. ...
Postmenopausal Hormone Replacement Therapy*Postmenopausal Hormone Replacement Therapy. *Hormone Replacement Therapy, Post- ... "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or ... "Estrogen Replacement Therapy" by people in Profiles.. * Klein KO, Phillips SA. Review of Hormone Replacement Therapy in Girls ... "Estrogen Replacement Therapy" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ...
Postmenopausal Hormone Replacement Therapy*Postmenopausal Hormone Replacement Therapy. *Hormone Replacement Therapy, Post- ... "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or ... "Estrogen Replacement Therapy" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... Estrogen Replacement Therapy*Estrogen Replacement Therapy. *Estrogen Replacement Therapies. *Replacement Therapies, Estrogen ...
Low estrogen in men may have serious health implications that require intervention to keep you feeling your best as you age. ... Low Estrogen In Men Could Be More Dangerous Than You Think. EstrogenHormone Replacement TherapyMen by Charlotte April 23, 2019 ... Depending on your needs, this may include using testosterone therapy to boost your testosterone levels and encourage estrogen ... Charlotte is a patient care coordinator specializing in bioidentical hormone replacement therapy. She is committed to helping ...
... is an important treatment for some women who want to relieve the symptoms of menopause. However, ... Oestrogen replacement therapy is a type of Hormone Replacement Therapy (HRT) that involves restoring oestrogen levels after ... For these reasons, a woman may wish to take oestrogen replacement therapy. The oestrogen is sourced from plants or from the ... Oestrogen Replacement Therapy and Risks to Womens Health. There is an elevated risk of certain kinds of cancer and an ...
... but estrogen replacement therapy may improve sleep quality to help you get some rest. ... Studies Show Estrogen Replacement Therapy May Improve Your Sleep. Estrogen replacement therapy may improve your menopause- ... Whether you need estrogen replacement therapy for menopause sleep issues or need CPAP therapy for sleep apnea, we are here to ... How Low Estrogen & Progesterone Affect Sleep for Menopausal Women. Why might estrogen replacement therapy be so beneficial for ...
... , Combination Estrogen Replacement, Estrogen-Only Hormone Replacement Therapy, Activella, ... Aka: Continuous Estrogen Replacement, Combination Estrogen Replacement, Estrogen-Only Hormone Replacement Therapy, Activella, ... Medications: Estrogen-Only Hormone Replacement Therapy * Estrogen must be taken with Progesterone if Uterus is intact ( ... Medications: Estrogen-Only Hormone Replacement Therapy * Preparations: Progestin Options (choose one to accompany an Estrogen ...
Adult Aged Estrogen Replacement Therapy Female Humans Middle Aged Osteoporosis, Postmenopausal Progestins Research Article Risk ... Estrogen replacement therapy (ERT) for postmenopausal women greatly reduces the risk of osteoporotic fractures, but carries an ... Barrett-Connor, E L "The risks and benefits of long-term estrogen replacement therapy." 104 (1989). Barrett-Connor, E L "The ... Title : The risks and benefits of long-term estrogen replacement therapy. Personal Author(s) : Barrett-Connor, E L Published ...
Estrogen replacement therapy: indications and complications. Ann Intern Med. 1983 Feb. 98(2):195-205. [QxMD MEDLINE Link]. ... 38] In patients who receive hormone replacement therapy with 0.625 mg of conjugated equine estrogens and 2.5 mg of ... Oral contraceptive use and estrogen replacement therapy. The mechanism for thromboembolic disease in women who use oral ... Both estrogens and progestogens are implicated in promoting thrombosis, even with low-dose therapy. [28, 29, 30, 31] All study ...
Estrogen replacement therapy: how much is too much?. Health and Medicine Reference Covering Thousands of Diseases and ... Estrogen replacement therapy: how much is too much?. From Townsend Letter for Doctors and Patients, 1/1/05 by Patrick Friel. ... In summary, the factors known to be associated with the most adverse outcomes in estrogen replacement therapy are: (1) use of ... it indicates elevated serum estrone in post-menopausal women receiving high-dose estrogen replacement therapy. The package ...
Ruggiero, Ronald J.; Likis, Frances E. (2002). "Estrogen: physiology, pharmacology, and formulations for replacement therapy". ... Estrogen is a critical sex hormone for women (in conjunction with progesterone). Estrogen is responsible for all different ... This termination of menses is associated with a dramatic drop in estrogen levels. The estrogen levels stated previously ... Androgen-dependent condition Estrogen insensitivity syndrome "Estrogen: Hormone, Function, Levels & Imbalances". Cleveland ...
Estrogen replacement therapy speeds ovarian cancer growth, new study reports. American Association for Cancer Research ... 19, 2010) - Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a ...
Barrett-Connor E, Kritz-Silverstein D ( 1993) Estrogen replacement therapy and cognitive function in older women. JAMA 269: ... Voytko ML ( 2000) The effects of long-term ovariectomy and estrogen replacement therapy on learning and memory in monkeys ( ... Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J ... and that themselves are regulated by estrogen (Gazzaley et al., 1996). Therefore, estrogen replacement at menopause might play ...
... we dive into the world of Estrogen Replacement Therapy (ERT) and its effects on our skin. We explore how ERT can help combat ... Benefits of Estrogen Replacement Therapy for Skin. Estrogen Replacement Therapy can help combat the adverse effects of ... Alternatives to Estrogen Replacement Therapy. If ERT is not suitable for you, or if youre hesitant about its risks, there are ... Understanding Estrogen Replacement Therapy. As we age, our body undergoes numerous changes, one of which is the decline in the ...
To investigate the effect of intranasal estrogen replacement therapy administered to postmenopausal women alone or in ... Keywords: Oxidised LDL, cardiovascular risk, postmenopausal woman, hormone replacement therapy, intranasal estrogen, ... risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy ... HORMONE-REPLACEMENT, MEDROXYPROGESTERONE ACETATE, OXIDATIVE SUSCEPTIBILITY, AORTIC ACCUMULATION, MENOPAUSAL WOMEN, EQUINE ...
Keywords: Clinically isolated syndrome; disability; disease progression; estrogen; hormone replacement therapy; menopause; ... There was no effect of hormone replacement therapy (HRT) exposure, but HRT use was low. ...
The effects of 14 days of estrogen replacement therapy (625μg conjugated estrogens) were studied in 20 healthy postmenopausal ... Two weeks of estrogen replacement therapy restored vascular NO activity to premenopausal levels. Changes in vascular NO ... Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. Lookup NU author(s): Dr ... We determined the effect of the menopause, gender, and estrogen replacement therapy on arterial vascular NO activity. Vascular ...
Menopause? Start estrogen replacement therapy sooner, to reduce heart disease. Glen Pyle, University of Guelph ... Research in mice shows that estrogen replacement therapy has the greatest chance of reducing cardiovascular disease risk if it ... New research shows that the timing of estrogen treatment is very important. (Unsplash/Eye for Ebony) June 4, 2019 ... Knee replacements can ease peoples pain - but they are also often prohibitively expensive. Dragana Gordic/Shutterstock ...
  • Hormone replacement therapy with estrogen and progesterone (HRT) is given if a woman has not had a hysterectomy (to avoid estrogenic endometrial stimulation and possible endometrial cancer in later life) or just estrogen replacement therapy (ERT) is used to diminish menopausal signs and symptoms and help prevent other medical problems. (wdxcyber.com)
  • HRT usually consists of an estrogen hormone plus a progesterone (progestin) hormone. (wdxcyber.com)
  • A lot of these issues may be due to hormone changes during menopause, particularly low estrogen and progesterone. (herkare.com)
  • To understand this, it's important to know how menopause affects sleep, especially through two hormones: estrogen and progesterone. (herkare.com)
  • Estrogen and progesterone are key hormones that control menstruation and pregnancy. (herkare.com)
  • Researchers are still studying how and why low estrogen and progesterone may interfere with good quality sleep. (herkare.com)
  • Your hormones may also affect your circadian rhythm, such as how estrogen and progesterone control menstruation. (herkare.com)
  • Therefore, estrogen and progesterone themselves may influence the processes in your body responsible for quality sleep. (herkare.com)
  • Estrogen is a critical sex hormone for women (in conjunction with progesterone). (wikipedia.org)
  • This therapy involves taking doses of estrogen, often in combination with another hormone called progesterone, to help restore the hormone balance in the body. (farmapram.su)
  • In particular, synthetic progesterone derivatives (progestins) such as medroxyprogesterone acetate (MPA), used in millions of women for hormone replacement therapy and contraceptives, markedly increase the risk of developing breast cancer. (nature.com)
  • MONTREAL, March, 29, 2019 /CNW Telbec/ - Pharmascience Inc. is proud to launch Pr pms-PROGESTERONE 200 mg (progestin), the only 200 mg progestin capsule available in Canada for women with an intact uterus as an adjunct to postmenopausal estrogen replacement therapy to significantly reduce the risk of endometrial hyperplasia and carcinoma. (trainitright.com)
  • Progesterone can be added to estrogen replacement therapy to avoid stimulation of the inner lining of the uterus and its cancer. (trainitright.com)
  • Estrogen therapy unopposed by progesterone therapy is a cause of endometrial cancer in women with an intact uterus. (cancer.gov)
  • However, women taking combination estrogen-progesterone therapy (hormone therapy) exhibit similar risk to women who do not take postmenopausal hormone therapy. (cancer.gov)
  • Most of the signs and symptoms of menopause result from the decrease in estrogen production, mainly estradiol. (wdxcyber.com)
  • Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. (ucdenver.edu)
  • Because a supply of testosterone is necessary for this conversion, low levels of testosterone can lead to even lower levels of estradiol and other estrogens. (bodylogicmd.com)
  • There are three different formulations of estrogen: estrone, estradiol, and estriol.These are commonly referred to as E1, E2, and E3, following the listing stated prior. (wikipedia.org)
  • Sixteen aged rhesus monkeys were ovariectomized, and throughout the course of subsequent neuropsychological assessment, half received a regimen of low-dose, cyclic estradiol replacement. (jneurosci.org)
  • the consumption of animal fat and protein (7) and alcohol (8), nonbreastfeeding (9), and use of oral contraceptives (10) and estrogen replacement therapy (11) have all been suggested. (cdc.gov)
  • Chamomile could interfere with the effects of tamoxifen , hormone replacement therapy, and estrogen-containing oral contraceptives. (msdmanuals.com)
  • Bioidentical estrogen is a form of bioidentical hormone replacement therapy (BHRT) . (anti-aging-bhrt.com)
  • Bioidentical hormone replacement therapy (BHRT) doctors require extensive testing, including urine testing, to assess the hormonal status of their patients and determine the most appropriate course of treatment. (bodylogicmd.com)
  • Doctors may also use blood tests and assess a patient's medical history, symptoms, and overall health to make informed decisions about bioidentical hormone replacement therapy. (bodylogicmd.com)
  • Customizing a bioidentical hormone replacement therapy (BHRT) program is essential because every individual's hormonal needs and health conditions are unique. (bodylogicmd.com)
  • BodyLogicMD affiliated physicians are the most highly trained in natural bioidentical hormone replacement therapy with integrated fitness and nutrition programs which they have been providing to their patients since 2003. (bodylogicmd.com)
  • Estrogen and progestin are two female sex hormones. (medlineplus.gov)
  • Estrogens are the class of hormones responsible for many female characteristics such as breast growth, body fat distribution, vaginal lubrication and lining thickness and uterine tissue growth. (wdxcyber.com)
  • The two hormones combined protect against endometrial cancer, a risk with estrogen taken alone. (wdxcyber.com)
  • Menopause is a natural process, and it causes levels of certain hormones, including estrogen , to decrease. (medicalnewstoday.com)
  • Hormones like estrogen are critical for regulating sexual desire in both men and women. (bodylogicmd.com)
  • LGBTQ+ Youth Consult Questions: Use of Sex Hormone Therapy Adolescence is a critical time for bone mineral density accrual, which is driven by sex hormones. (medscape.com)
  • Steroid hormones can be grouped into five groups by the receptors to which they bind: glucocorticoids, mineralocorticoids, androgens, estrogens, and progestogens. (absoluteastronomy.com)
  • Hormone replacement therapy for transgender and transsexual people changes the balance of sex hormones in their bodies. (absoluteastronomy.com)
  • Hormone replacement therapy, especially when involving bioidentical hormones, needs careful monitoring to ensure patient safety. (bodylogicmd.com)
  • Known estrogen-dependent conditions include: mastodynia (breast pain/tenderness) breast fibroids mammoplasia (breast enlargement) macromastia (breast hypertrophy) gynecomastia breast cancer precocious puberty in girls and isosexual precocious puberty in boys melasma menorrhagia endometriosis endometrial hyperplasia adenomyosis uterine fibroids uterine cancers (e.g., endometrial cancer) ovarian cancer hyperestrogenism and associated feminization in males such as in certain conditions like cirrhosis, Klinefelter's syndrome, and aromatase excess syndrome. (wikipedia.org)
  • 2 ] Age-adjusted endometrial cancer incidence in the United States increased from the mid-1960s to 1975 and then declined from 1975 to 1980, with a transient increase in incidence occurring from 1973 to 1978, which was associated with estrogen therapy, also known as hormone therapy. (cancer.gov)
  • 4 - 8 ] Tamoxifen therapy is also a cause of endometrial cancer. (cancer.gov)
  • In addition to the increased risk of developing endometrial cancer that is observed in women who use unopposed estrogen therapy or tamoxifen, a number of additional risk factors have been identified, and most appear to be related to estrogenic effects. (cancer.gov)
  • The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, dyspareunia, and progressive development of osteoporosis. (usda.gov)
  • A small number of men are affected by estrogen hormonal imbalance as well. (anti-aging-bhrt.com)
  • Bioidentical estrogen refers to a hormonal treatment designed to combat problems with estrogen imbalance. (anti-aging-bhrt.com)
  • In addition, rising drug development and hormonal imbalance disorders with rising geriatric population are also boosting the hormone replacement therapy market growth. (medgadget.com)
  • Additionally, the rising women's population between the age group of 45 to 60, which increases the range of menopausal window due to this factor the demand of hormonal replacement therapy, is also growing. (medgadget.com)
  • By tailoring the therapy to each patient, healthcare providers can optimize the benefits of BHRT while minimizing potential risks, helping individuals achieve better hormonal balance and overall well-being. (bodylogicmd.com)
  • If you are having surgery or will be on bedrest, talk to your doctor about stopping estrogen and progestin at least 4 to 6 weeks before the surgery or bedrest. (medlineplus.gov)
  • Talk to your doctor about the risks and benefits of taking estrogen and progestin. (medlineplus.gov)
  • Combinations of estrogen and progestin are used to treat certain symptoms of menopause. (medlineplus.gov)
  • Progestin is added to estrogen in hormone replacement therapy to reduce the risk of uterine cancer in women who still have their uterus. (medlineplus.gov)
  • Activella, FemHrt, and Prempro come as tablets containing estrogen and progestin. (medlineplus.gov)
  • Take one pink tablet (containing only estrogen) once daily for 3 days, then take one white tablet (containing estrogen and progestin) once daily for 3 days. (medlineplus.gov)
  • Take one maroon tablet (containing only estrogen) once daily on days 1 to 14, and take one light-blue tablet (containing estrogen and progestin) once daily on days 15 to 28. (medlineplus.gov)
  • tell your doctor and pharmacist if you are allergic to estrogen, progestin, or any other medications. (medlineplus.gov)
  • Over the last two years, the Women's Health Initiative, a series of long-term studies funded by the National Institutes of Health, revealed that taking an estrogen-progestin combination slightly increases the risk of stroke and blood clots and may also increase the risk of heart disease, breast cancer, and dementia. (discovermagazine.com)
  • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. (nature.com)
  • On the other hand, combination HRT with estrogen-progestin also increases your risk, but this may go down slightly after you stop taking it. (healthline.com)
  • Estrogen reduces feelings of warmth in the upper body and periods of sweating and heat (hot flashes), vaginal symptoms (itching, burning, and dryness) and difficulty with urination, but it does not relieve other symptoms of menopause such as nervousness or depression. (medlineplus.gov)
  • Though the results were deemed statistically insignificant, the news was that it flew in the face of most previous studies," says Vivian Dickerson, president of the American College of Obstetricians and Gynecologists, who argues that the study should not inhibit women from using hormone replacement in early menopause to relieve symptoms such as hot flashes and mood swings. (discovermagazine.com)
  • The dose and form and regimen for the medications are determined depending on the individual woman's background, current symptoms number of years post menopause, family history, medical history, and goals for the replacement therapy. (wdxcyber.com)
  • Also, estrogen cream is and slow hormone release silicone rings are available that can be prescribed to relieve vaginal symptoms. (wdxcyber.com)
  • For most women, having imbalanced estrogen leads to a number of difficult side effects and symptoms. (anti-aging-bhrt.com)
  • There are many different symptoms of estrogen imbalance , which range from mild to severe. (anti-aging-bhrt.com)
  • While it's not for everyone, in the right situations bioidentical estrogen can eliminate the symptoms of estrogen imbalance . (anti-aging-bhrt.com)
  • While it's unclear whether low estrogen in men is always harmful, there are a number of symptoms that may be associated with lower estrogen than normal in certain narrow populations of men. (bodylogicmd.com)
  • While the men with lower bone mineral density did not report any negative symptoms, the risk is that in the absence of estrogen, their bones could slowly become weaker and less dense without betraying any specific symptoms which a man might notice. (bodylogicmd.com)
  • When oestrogen levels fall from a change such as menopause, women will usually experience a range of symptoms. (menopauseexpert.co.uk)
  • Women who have a strong family history of certain diseases such as breast cancer may prefer to avoid oestrogen replacement therapy and instead, find alternate ways to treat menopause symptoms. (menopauseexpert.co.uk)
  • There are many ways to relieve menopause symptoms - oestrogen replacement therapy is only one of a number of effective treatments for menopause symptoms. (menopauseexpert.co.uk)
  • However, these results are promising that estrogen replacement therapy may be able to reduce many sleep symptoms associated with menopause. (herkare.com)
  • Estrogen replacement therapy (ERT) is a treatment often recommended by doctors to combat the symptoms of menopause, which are primarily brought about by the decrease in estrogen levels. (farmapram.su)
  • Studies show that estrogens, commonly prescribed in menopause, maintain the woman's bone structure and prevent fractures caused by osteoporosis as well as help relieve the symptoms associated with their condition. (trainitright.com)
  • Hormone replacement therapy is a treatment used to release symptoms of the menopause. (medgadget.com)
  • after a massive study of hormone replacement therapy was halted due to higher rates of breast cancer, heart attack and stroke among women assigned to the drugs to treat menopausal symptoms, a new follow-up study has found those women had no higher risk of death as of 2014 than participants who took a placebo. (medgadget.com)
  • Selective estrogen receptor modulators (SERM) are a class of medications used to relieve postmenopausal symptoms and to prevent bone loss ( osteoporosis ) associated with menopause . (rxlist.com)
  • Estrogen-like to relieve menopausal vasomotor symptoms and vaginal dryness. (rxlist.com)
  • Stevenson JC, Chines A, Pan K, Ryan KA, Mirkin S. A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials. (jefferson.edu)
  • Such conditions may be treated with drugs with antiestrogen actions, including selective estrogen receptor modulators (SERMs) such as tamoxifen and clomifene, estrogen receptor antagonists such as fulvestrant, aromatase inhibitors such as anastrozole and exemestane, gonadotropin-releasing hormone (GnRH) analogues such as leuprorelin and cetrorelix, and/or other antigonadotropins such as danazol, gestrinone, megestrol acetate, and medroxyprogesterone acetate. (wikipedia.org)
  • Verdier-Sevrain S. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. (imsociety.org)
  • Pharmacologic therapy for osteoporosis includes most commonly the use of antiresorptive agents to decrease bone resorption, such as bisphosphonates, denosumab, and the selective estrogen-receptor modulator (SERM) raloxifene. (medscape.com)
  • How Do Selective Estrogen Receptor Modulators Work? (rxlist.com)
  • Selective estrogen receptor modulators work by modulating the activity of estrogen receptors, proteins in cells that are activated by estrogen. (rxlist.com)
  • Selective estrogen receptor modulators have both estrogen agonistic and antagonistic properties, depending on the type of tissue. (rxlist.com)
  • Selective estrogen receptor modulators may also be combined with estrogen for postmenopausal women with an intact uterus, who are undergoing estrogen replacement therapy. (rxlist.com)
  • How are selective estrogen receptor modulators used? (rxlist.com)
  • What are side effects of selective estrogen receptor modulators? (rxlist.com)
  • Find out how vaginal oestrogen treats vaginal dryness caused by menopause, and how to take it. (www.nhs.uk)
  • The effects of 14 days of estrogen replacement therapy (625μg conjugated estrogens) were studied in 20 healthy postmenopausal women (60 yr). (ncl.ac.uk)
  • Oestrogen has many important roles in the body such as encouraging a healthy bone density and keeping the vagina moist. (menopauseexpert.co.uk)
  • Some studies have linked drinking milk with higher risk of oestrogen-receptor positive breast cancer. (theconversation.com)
  • When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. (the-medical-dictionary.com)
  • Two types of estrogen receptor exist: ER, which is a member of the nuclear hormone family of intracellular receptors, and the estrogen G protein-coupled receptor GPR30 , which is a G protein-coupled. (absoluteastronomy.com)
  • Background The oestrogen receptor beta (ERβ) is the predominant oestrogen receptor in the normal colon mucosa and has been reported to exert anti-proliferative and pro-apoptotic effects. (lu.se)
  • Estrogen also prevents thinning of the bones (osteoporosis) in menopausal women. (medlineplus.gov)
  • How does estrogen affect osteoporosis? (medicalnewstoday.com)
  • Low estrogen levels can lead to porous, weakened bones and osteoporosis. (medicalnewstoday.com)
  • Below, learn how estrogen influences osteoporosis, how to prevent the condition, and what the treatments entail. (medicalnewstoday.com)
  • How does estrogen help with osteoporosis? (medicalnewstoday.com)
  • Some people use estrogen replacement therapy (ERT) to prevent or reverse osteoporosis. (medicalnewstoday.com)
  • When a person has low levels of estrogen, they have an increased risk of osteoporosis and fractures. (medicalnewstoday.com)
  • Men who don't have the estrogen necessary to enable bone health may experience deviant bone growth, much slower healing of fractures, and have a higher risk for osteoporosis, especially if they were also deficient during their youth. (bodylogicmd.com)
  • Hormone Replacement Therapy for Postmenopausal Osteoporosis Postmenopausal women are at increased risk for fractures. (medscape.com)
  • Hormone replacement therapy can also reduce a woman's risk of developing osteoporosis and cancer of the colon and rectum. (medgadget.com)
  • On the one hand, estrogen has some important benefits, such as decreasing a woman's risk for osteoporosis . (memorylossonline.com)
  • Block estrogen activity in the breast and uterus , reducing the risk of breast cancer and endometrial hyperplasia (thickening). (rxlist.com)
  • In recent years, a few preliminary studies suggested that post-menopausal women who take estrogen are less likely to develop Alzheimer's than women who do not. (memorylossonline.com)
  • In June researchers from the Women's Health Initiative Memory Study added a dismal confirmation: estrogen-only replacement therapy in postmenopausal women who've had a hysterectomy not only fails to prevent memory loss but may also increase the risk of dementia. (discovermagazine.com)
  • The study tracked 2,947 women, ages 65 to 79, over five years and found that 28 of the women on estrogen developed dementia, compared with only 19 of those on placebos. (discovermagazine.com)
  • Estrogen therapy alone may be used for women who have had a hysterectomy. (wdxcyber.com)
  • Estrogen imbalance primarily affects women who are entering and going through menopause. (anti-aging-bhrt.com)
  • To update for both clinicians and the lay public the evidence-based position statement published by The North American Menopause Society (NAMS) in March 2007 regarding its recommendations for menopausal hormone therapy (HT) for postmenopausal women, with consideration for the therapeutic benefit-risk ratio at various times through menopause and beyond. (nih.gov)
  • Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women. (jefferson.edu)
  • Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. (jefferson.edu)
  • Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial. (ucdenver.edu)
  • Does estrogen provide "neuroprotection" for postmenopausal women? (ucdenver.edu)
  • In men and women alike, estrogen is implicated in social behavior, bonding, and more-but the relationship between having low levels of estrogen and having difficulty with these behaviors or performing them at the right frequency remains ambiguous. (bodylogicmd.com)
  • This kind of oestrogen is generally recommended for women who have had their ovaries and womb removed through a procedure called a hysterectomy. (menopauseexpert.co.uk)
  • There is a widespread belief that oestrogen replacement therapy will make women gain weight but this is not usually the case. (menopauseexpert.co.uk)
  • This means that for most women who wish to take oestrogen replacement therapy, a shorter course of less than five years is preferable to a longer course of the treatment. (menopauseexpert.co.uk)
  • However, estrogen replacement therapy may improve sleep quality for menopausal women. (herkare.com)
  • Therefore, many scientists have looked at the effects of estrogen replacement therapy on sleep and whether it can help menopausal women sleep better. (herkare.com)
  • The experts were unanimous: 'estrogens cause cancer, and women shouldn't take them. (the-medical-dictionary.com)
  • Aurora, Colo. (Oct. 19, 2010) - Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center. (scienceblog.com)
  • Among the identified risks and benefits of hormone-replacement therapy, the effects of treatment on cognitive function in postmenopausal women have proved difficult to define. (jneurosci.org)
  • The Women's Health Initiative and the Million Women Study have shown that hormone replacement therapy is associated with an increased risk of incident and fatal breast cancer 2 , 3 . (nature.com)
  • Beral, V. Breast cancer and hormone-replacement therapy in the Million Women Study. (nature.com)
  • The aims of the study were to establish the current prevalence of skin disorders in a group of peri- and postmenopausal women and to investigate any perceived effects of hormone therapy (HT) on the skin. (imsociety.org)
  • A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. (imsociety.org)
  • Does hormone therapy improve age-related skin changes in postmenopausal women? (imsociety.org)
  • And until research establishes otherwise, women deciding whether to take hormone replacement therapy should not allow concern over Alzheimer's disease to outweigh other proven considerations. (memorylossonline.com)
  • Even with these caveats, however, phytoestrogens could still be part of an alternative to hormone replacement therapy for post-menopausal women. (memorylossonline.com)
  • or 10 mg daily in postmenopausal women not receiving estrogen. (nih.gov)
  • There may be a relationship between estrogen and the sema3A protein in osteocytes. (medicalnewstoday.com)
  • Review of Hormone Replacement Therapy in Girls and Adolescents with Hypogonadism. (jefferson.edu)
  • is determined in men when reduced testosterone production is suspected, e.g. in hypogonadism, estrogen therapy, chromosome aberrations (as in the Klinefelter's syndrome) and liver cirrhosis. (cdc.gov)
  • Estrogen , commonly dubbed the "female hormone," regulates secondary sexual characteristics in the body. (anti-aging-bhrt.com)
  • Overview of Dietary Supplements Dietary supplements are the most commonly used of all integrative, complementary, and alternative therapies, primarily because they are widely available, relatively inexpensive, and can be bought. (msdmanuals.com)
  • Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials. (jefferson.edu)
  • If you both decide to proceed with ERT, they will prescribe the appropriate dosage and form of estrogen for you. (farmapram.su)
  • For this reason, doctors do not generally prescribe estrogen solely for prevention of Alzheimer's. (memorylossonline.com)
  • The longer you take oestrogen replacement therapy, the greater the risks. (menopauseexpert.co.uk)
  • Whatever you choose, try to make your choice based on a thorough discussion with your doctor about the risks and benefits of oestrogen replacement therapy. (menopauseexpert.co.uk)
  • The risks and benefits of long-term estrogen replacement therapy. (cdc.gov)
  • Therefore, it is crucial to discuss these risks with your healthcare provider before starting the therapy. (farmapram.su)
  • The National Institute on Aging (NIA) offers a comprehensive and easily understandable primer about menopause, including a concise explanation of the known risks and benefits associated with hormone replacement therapy. (memorylossonline.com)
  • Future research may clarify the behavioral effects of low estrogen in men, but the existing evidence offers intriguing glimpses into the possibilities. (bodylogicmd.com)
  • There are side effects that you might notice if you do choose to take oestrogen replacement therapy. (menopauseexpert.co.uk)
  • The animal model established here should enable progress toward defining the neurobiological mechanisms that mediate the beneficial effects of estrogen on age-related cognitive decline in primates. (jneurosci.org)
  • Research on the cognitive effects of hormone-replacement therapy (HRT), for example, is complicated by the difficulty of matching treatment and control groups according to chronological age, education, overall health status, and other subject characteristics that can influence neuropsychological function independent of ovarian hormone status. (jneurosci.org)
  • Here we adopted a controlled, prospective design in a nonhuman primate model to test the effects of ovariectomy and estrogen replacement on normal cognitive aging. (jneurosci.org)
  • Estrogen Replacement Therapy can help combat the adverse effects of declining estrogen levels on our skin. (farmapram.su)
  • Episode 1: Androgen Deprivation Therapy and Prostate Cancer Drs Sandhya Srinivas and Rana R. McKay discuss bone health and survivorship, including risk factors and potential side effects with androgen deprivation therapy in patients with prostate cancer. (medscape.com)
  • Leitch C, Doherty V, Gebbie A. Womens perceptions of the effects of menopause and hormone replacement therapy on skin. (imsociety.org)
  • Estrogen and skin: the effects of oestrogen, menopause, and hormone replacement therapy on the skin. (imsociety.org)
  • However, the hormone replacement therapy has number of side effects which may hamper the market growth. (medgadget.com)
  • By analyzing urine samples, doctors can track hormone levels over time and ensure that hormone replacement is achieving the desired effects. (bodylogicmd.com)
  • SERMs bind to estrogen receptors and activate estrogen pathways in some tissue while blocking its effects in other types of tissue. (rxlist.com)
  • Although phytoestrogens have a chemical structure similar to estrogen, there is no good evidence that phytoestrogens have the same effects as estrogen in the human body. (memorylossonline.com)
  • SERMs reduce the risk of endometrial hyperplasia that can occur with estrogen therapy. (rxlist.com)
  • To produce estrogen, these organs chemically convert testosterone into estrogens using an enzyme called aromatase. (bodylogicmd.com)
  • While low testosterone may happen at any age, testosterone levels steadily drop as you age , making it more likely that you will have correspondingly low estrogen levels. (bodylogicmd.com)
  • Because men rely heavily on testosterone, estrogen appears to have only a niche role in male health, which means that there isn't a single symptomatic profile of low estrogen levels in men. (bodylogicmd.com)
  • Some men may experience low libido if their estrogen levels are too low-but only if their testosterone levels are also lower than they should be. (bodylogicmd.com)
  • Researchers have found that in men with diminished testosterone levels, low levels of estrogen may contribute to low libido in some cases. (bodylogicmd.com)
  • Based upon product, global hormone replacement therapy market is classified into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy and testosterone replacement therapy. (medgadget.com)
  • Nonetheless, estrogen deficiency may still be harmful to men in a number of ways, potentially compromising bone health, behavioral health, and sexual desire. (bodylogicmd.com)
  • In adulthood, however, estrogen deficiency can silently affect male bones for years before the impact is noticeable. (bodylogicmd.com)
  • People assigned female at birth who are postmenopausal and take hormone replacement therapy (HRT) , also called menopausal hormone therapy, may especially be at risk. (healthline.com)
  • Data regarding use of estrogen plus progestogen or estrogen alone were obtained in interviews. (kaiserpermanente.org)
  • Hormone replacement therapy may increase the risk of heart attack, stroke, breast cancer, and blood clots in the lungs and legs. (medlineplus.gov)
  • Research in mice shows that estrogen replacement therapy has the greatest chance of reducing cardiovascular disease risk if it is begun soon after menopause. (theconversation.com)
  • Oestrogen replacement therapy is associated with an increased risk of breast cancer, stroke and other conditions. (menopauseexpert.co.uk)
  • You should speak to your doctor about a risk evaluation before choosing to take oestrogen replacement therapy. (menopauseexpert.co.uk)
  • Shortly after the combined therapy arm of the Women's Health Initiative (WHI) Study (which concluded that Prempro (1) increases a woman's risk of breast cancer, stroke, and cardiovascular disease) was halted, a group of women's health experts were interviewed on Seattle's public radio station. (the-medical-dictionary.com)
  • Changes in vascular NO activity may contribute to changes in cardiovascular risk associated with male gender, postmenopausal status, and estrogen replacement therapy. (ncl.ac.uk)
  • Combined hormone replacement therapy slightly increases the risk of developing breast cancer, womb cancer, ovarian cancer and stroke. (medgadget.com)
  • Nor have there been long-term studies establishing whether the supplements are safe in large doses, or whether phytoestrogen use carries the same risk of cancer as estrogen use. (memorylossonline.com)
  • Can Estrogen Increase Your Risk of Breast Cancer? (healthline.com)
  • High amounts of estrogen or prolonged exposure throughout your life may increase your risk of breast cancer. (healthline.com)
  • However, in some cases, increased estrogen exposure over your lifetime may increase your risk of developing breast cancer. (healthline.com)
  • In this article, we take a closer look at estrogen, including when and why it may increase your risk of developing breast cancer and steps you can take to lower your risk. (healthline.com)
  • According to the National Cancer Institute , estrogen-only HRT may increase your risk of breast cancer, and this risk does not decrease if you stop taking the medication. (healthline.com)
  • While HRT may increase your risk of breast cancer, there are other factors that can increase your estrogen exposure and subsequent cancer risk. (healthline.com)
  • What are the non-estrogen-related risk factors of breast cancer? (healthline.com)
  • Aside from estrogen exposure, other factors may increase your lifetime risk of developing breast cancer . (healthline.com)
  • Breastfeeding may also slightly decrease your risk because of a smaller number of menstrual cycles over your lifetime, which decreases estrogen exposure. (healthline.com)
  • The estrogen levels stated previously dramatically decrease to approximately 20 pg/ml or less when menopause begins. (wikipedia.org)
  • Hormone replacement therapy works by replacing estrogen hormone that is no longer being made by the body. (medlineplus.gov)
  • Hormone replacement therapy comes as a tablet to take by mouth. (medlineplus.gov)
  • To help you remember to take hormone replacement therapy, take it around the same time every day. (medlineplus.gov)
  • Before taking hormone replacement therapy, ask your pharmacist or doctor for a copy of the manufacturer's information for the patient and read it carefully. (medlineplus.gov)
  • For years hormone replacement therapy was promoted as a defense against a host of age-related ailments. (discovermagazine.com)
  • And the study did not address whether hormone replacement therapy given during early menopause might offer cognitive protection. (discovermagazine.com)
  • Backeljauw P, Klein K. Sex hormone replacement therapy for individuals with Turner syndrome. (jefferson.edu)
  • Oestrogen replacement therapy is a type of Hormone Replacement Therapy (HRT) that involves restoring oestrogen levels after they have begun to decline due to the menopausal transition. (menopauseexpert.co.uk)
  • Much of the evidence suggests that hormone replacement therapy can improve sleep. (herkare.com)
  • There was no effect of hormone replacement therapy (HRT) exposure, but HRT use was low. (nih.gov)
  • Hormone replacement therapy, particularly estrogen, can be beneficial. (medscape.com)
  • The latest research report on Hormone Replacement Therapy Market delivers a comprehensive study on current market trends. (medgadget.com)
  • Systemic hormone replacement therapy helps in treating cancer, rheumatoid arthritis and other diseases. (medgadget.com)
  • Global Hormone Replacement Therapy market report is segmented on the basis of product, administration, disease and region & country level. (medgadget.com)
  • The regions covered in this Hormone Replacement Therapy market report are North America, Europe, Asia-Pacific and Rest of the World. (medgadget.com)
  • The Growing Awareness about Hormone Replacement is the Key Factor Influencing the Global Hormone Replacement Therapy Market Growth. (medgadget.com)
  • Furthermore, high ERβ expression was significantly correlated with shorter breastfeeding time and longer use of hormone replacement therapy. (lu.se)
  • As we age, our body undergoes numerous changes, one of which is the decline in the production of estrogen. (farmapram.su)
  • Estrogen Replacement Therapy and Longitudinal Decline in Visual Memory. (bvsalud.org)
  • Estrogen is a type of female reproductive hormone primarily produced by the ovaries, skin, and fat tissues. (healthline.com)
  • Estrogen receptors and inflammation in colorectal cancer. (lu.se)
  • ERT involves taking artificial estrogen to increase estrogen levels in the body. (medicalnewstoday.com)
  • However, estrogens are critical for bone health in both sexes, especially during youth, when the rate of bone growth is high. (bodylogicmd.com)
  • Estrogen is a hormone that has many important functions including the development of female secondary sexual characteristics, regulation of reproductive cycle, and maintenance of bone health. (rxlist.com)
  • Eighty percent of patients had significant response to therapy, with 70% showing diagnosti. (psychiatrist.com)
  • The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? (ucdenver.edu)
  • Fluctuating estrogen levels accompany the perimenopausal transition. (psychiatrist.com)
  • When estrogen levels drop - for example, during menopause - a person may lose bone density. (medicalnewstoday.com)
  • Low estrogen levels affect how these cells function, making them produce too little new bone and not properly maintain bone structure. (medicalnewstoday.com)
  • As people age, their levels of estrogen and sema3A deplete, which leaves the bones unable to maintain their structure. (medicalnewstoday.com)
  • Estrogen levels can be tested in urine, blood and saliva. (anti-aging-bhrt.com)
  • But what most men may not know is that their estrogen levels can also be an important contributor to their overall health. (bodylogicmd.com)
  • In a retrospective study of a group of 1,185 adult men, men with clinically low estrogen levels had a bone mineral density of 0.93 grams per square centimeter, whereas men with normal estrogen levels had a bone mineral density of 1.02 grams per square centimeter. (bodylogicmd.com)
  • This termination of menses is associated with a dramatic drop in estrogen levels. (wikipedia.org)
  • Two weeks of estrogen replacement therapy restored vascular NO activity to premenopausal levels. (ncl.ac.uk)
  • A change in TBG blood levels can alter the appropriate dose of levothyroxine replacement for persons with hypothyroidism. (medlineplus.gov)
  • [ 9 ] It too found higher rates of cardiovascular events starting at Lp(a) levels greater than 30 mg/dL or 50 mg/dL in patients receiving statin therapy. (medscape.com)
  • Genome-wide association studies first identified that Lp(a) was associated with aortic stenosis and aortic valve replacement , [ 14 ] and subsequent imaging studies confirmed that higher Lp(a) levels are associated with worsening progression of aortic stenosis, suggesting it has a direct causal effect. (medscape.com)
  • This is because fat tissues store and release estrogen, which can increase overall estrogen levels. (healthline.com)
  • In a normal adult female, the normal range of estrogen in the luteal phase (when ovulation happens, as well as the vascular tissue preparing for the potential zygote ) is 100 pg/ml, in comparison to the proliferative phase (when the uterine lining is thickening) 40-250 pg/ml. (wikipedia.org)
  • Treat with one of the following (followed by antiresorptive therapy, e.g. (fpnotebook.com)
  • Both the egg donor and the surrogate mother will undergo estrogen replacement therapy once menstruation begins. (sharedjourney.com)
  • This regimen eventually leads to the complete absence of any vaginal bleeding after several months of therapy. (wdxcyber.com)
  • 4) If a patient is receiving long-term prophylactic treatment with one of the protocol-allowed therapies, they must have been on a stable dose and regimen for at least 3 months prior to the Screening Visit and be willing to remain on a stable dose and regimen for the duration of the trial. (who.int)
  • Why might estrogen replacement therapy be so beneficial for sleep quality after menopause? (herkare.com)
  • Bioidentical estrogen treatment typically begins only after an estrogen level test reveals an estrogen imbalance. (anti-aging-bhrt.com)
  • For instance, if pills are not tolerable, you could switch to an oestrogen patch. (menopauseexpert.co.uk)
  • But because this phenomenon has not yet been studied using human males, you probably can't consider compulsive behavior to be a symptom of low estrogen in men. (bodylogicmd.com)